Compare os principais médicos e preços de Quimioterapia do linfoma em Israel. Encontre o seu melhor par aqui.
Vamos selecionar os melhores médicos com base nas suas necessidades e orçamento.
Revisado por Fahad Mawlood
Editor médico e cientista de dadosMelhores médicos
16
Israel
Avaliações
14000+
De pacientes reais
Compare os preços de Quimioterapia do linfoma entre os principais países
Toque em um país para ver os principais médicos e preços
Receba planos de tratamento personalizados gratuitos e escolha a melhor opção. Sem compromisso · Sem pagamentos pelos nossos serviços
Mostrar primeiro:
O Dr. Ram Ron é especializado em quimioterapia para linfomas no Sourasky Medical Center (Ichilov), trazendo vasta experiência para casos complexos.
Chefe de Onco-Hematologia Pediátrica no Hospital Infantil Dana Dwek – O Dr. El Hasid é especializado em transplantes de medula óssea e de sangue de cordão umbilical. Realizou mais de 300 procedimentos.
O Dr. Ron Ram realizou várias centenas de transplantes de células-tronco, demonstrando sua profunda experiência no tratamento de linfoma no Centro Médico Sourasky.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Especializado em Transplante de Medula Óssea – Dr. Shapira traz experiência focada em quimioterapia para linfoma no Centro Médico Sourasky.
O Dr. Dror Levin é um especialista líder em distúrbios sanguíneos pediátricos e câncer ósseo, dirigindo o departamento de hematologia e oncologia no Sourasky Medical Center.
31 anos de experiência em onco-hematologia – O Dr. Aviv é especialista em quimioterapia para linfomas no Sourasky Medical Center (Ichilov).
Dr. Herishanu Yair ganhou vários prêmios por sua pesquisa em leucemia linfocítica crônica e hematologia no Centro Médico Sourasky.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Chefe de Hematologia no Centro Médico Hadassah – A Professora Ben-yehuda foi pioneira na terapia genética e nos transplantes de medula óssea para linfoma.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Escolher clínica no exterior pode ser estressante. No Bookimed, com mais de 800K pacientes atendidos, entendemos preocupações. Sabemos encontrar médicos confiáveis, melhores opções de custo-benefício e soluções até para casos complexos. Estamos aqui para orientar em cada etapa.
Yan Matsiivskiy
Chefe da Equipe de Coordenadores Médicos
4300++ jornadas de pacientes acompanhadas
3 anos na Bookimed
142 pacientes de Israel encontraram seu médico conosco este mês
Quiz de 2 minutos
Conte-nos seu objetivo, orçamento e prazo
Combinação Humana + IA
Nosso algoritmo encontra correspondências, o coordenador verifica a adequação
Suas opções prontas
Compare preços, pacotes, datas. Converse com seu coordenador
Muitas opções?
Orientando seu tratamento
Coordenadores pessoais com formação médica
| Classificação | Médico | experiência | Bom para | O que os diferencia | Clínica e localização | Consulta |
|---|---|---|---|---|---|---|
| #1 | 24 anos de experiência | Casos complexos de linfoma | Especializa-se em quimioterapia complexa para linfomas, contando com vasta experiência. Realizou a sua formação de especialização avançada (Fellowship) no Ronald O Perelman and Claudia Cohen Centre. | Israel | Preço sob consulta | |
| #2 | 38 anos de experiência | Tratamento de linfoma pediátrico | Oncologista de destaque focado exclusivamente em casos pediátricos, com mais de 300 transplantes realizados. Chefia um departamento especializado em um dos principais hospitais infantis de Israel. | Israel | Preço sob consulta | |
| #3 | 24 anos de experiência | Transplantes de células-tronco | Especialista em transplantes de células-tronco com vasta experiência. Publicou mais de 30 artigos científicos e contribuiu para um livro didático de medicina. | Israel | Preço sob consulta | |
| #4 | 36 anos de experiência | Transplante de medula óssea | Especializa-se exclusivamente em transplante de medula óssea – médico sênior no renomado programa de Hadassah. Fluente em inglês e hebraico para pacientes internacionais. | Israel | Preço sob consulta | |
| #5 | 41 anos de experiência | Linfoma e sarcoma pediátricos | É especialista em distúrbios sanguíneos pediátricos e câncer ósseo – dirige um departamento de hematologia e oncologia líder. Treinamento realizado em instituições de ponta, incluindo o Instituto Ortopédico Rizzoli. | Israel | Preço sob consulta | |
| #6 | 34 anos de experiência | Quimioterapia para linfoma | Especializado em cânceres do sangue com três décadas de experiência. Oferece planos de tratamento personalizados no principal centro médico de Israel. | Israel | Preço sob consulta | |
| #7 | 24 anos de experiência | Leucemia linfocítica crônica | Hematologista premiado(a), especializado(a) em leucemia linfocítica crônica. Reconhecido(a) pela excelência clínica e pelas contribuições de pesquisa em hematologia. | Israel | Preço sob consulta | |
| #8 | 34 anos de experiência | Casos de linfoma avançado | Pioneira em terapia genética e transplantes de medula óssea para linfoma. Primeira mulher Decana da Faculdade de Medicina Hadassah, com formação no Sloan-Kettering. | Israel | Preço sob consulta |
Israel features world-renowned hematology experts who hold board certifications in internal medicine and medical oncology. These specialists often complete elite fellowships at institutions like Stanford University or Memorial Sloan-Kettering. Many lead dedicated bone marrow transplant units at JCI-accredited centers in Tel Aviv and Jerusalem.
Bookimed Expert Insight: Data shows a high concentration of expertise at Sourasky Medical Center, where doctors like Dr. Fredi Aviv bring 30+ years of experience. At Sheba Medical Center, Professor Arnon Nagler is a global pioneer who founded the country’s first public cord blood bank. This high level of specialization in both chemotherapy and transplantation provides patients with comprehensive care under one roof.
Patient Consensus: Patients note that the hospital infrastructure and access to multidisciplinary teams are just as vital as the doctor's reputation. They appreciate that oncology teams in major urban centers speak English fluently, making the complex process much easier. Many suggest getting multiple opinions before starting protocols to feel confident in the chosen treatment plan.
When choosing a lymphoma chemotherapy doctor in Israel, focus on hematologists with international fellowship training and board certification in medical oncology. Top specialists often hold leadership roles in bone marrow transplant departments and maintain memberships in the American Society of Hematology to stay current with global protocols.
Bookimed Expert Insight: Data shows that choosing a doctor who also heads a specialized department, such as Dr. Ron Ram or Dr. Ronit El Hasid, provides a distinct advantage. These leaders often manage both chemotherapy and stem cell transplant programs, ensuring a seamless transition if initial treatments require more intensive cell therapy later.
Patient Consensus: Patients note that clear communication about side effects significantly reduces their anxiety during the infusion process. They often feel more confident when their hematologist provides a tailored plan that includes consistent post-treatment follow-up and access to supportive hospital staff.
Israel offers top-tier pediatric lymphoma specialists at world-class oncology centers. These experts specialize in advanced therapies and bone marrow transplants for children. Leading doctors like Dr. Ronit El Hasid and Dr. Dror Levin provide specialized care for young patients with blood disorders.
Bookimed Expert Insight: Data shows a concentration of elite pediatric oncology expertise at JCI-accredited facilities in Tel Aviv. For example, Dr. Ronit El Hasid and Dr. Dror Levin both practice at Sourasky Medical Center. This allows families to access multiple specialists for complex lymphoma cases within a single high-ranking hospital.
Patient Consensus: Parents describe the medical teams as precise and notice fewer side effects during chemotherapy. Many families feel relieved by the short wait times for starting personalized treatment protocols. They appreciate that major centers provide English-fluent staff to help navigate the care process smoothly.
Israel offers advanced lymphoma treatments through world-recognized hematologists specializing in CAR T-cell therapy and molecular diagnostics. Leading specialists at JCI-accredited centers like Sheba and Sourasky (Ichilov) provide innovative cellular therapies. Most experts hold fellowships from top-tier US institutions like Stanford and Mayo Clinic.
Bookimed Expert Insight: Israeli hematology centers often develop in-house CAR-T protocols rather than relying only on commercial brands. At Sheba Medical Center, these internal laboratory capabilities can significantly reduce the cell preparation time. Patients benefit from localized manufacturing which may streamline the treatment timeline for aggressive lymphoma types.
Patient Consensus: Patients note that targeted therapies like ibrutinib are often more accessible than CAR T-cell programs. Many mention the importance of verifying eligibility for specific lymphoma subtypes before starting the travel process. Some patients feel more confident after getting a second opinion to validate their intensive treatment plans.
Finding and booking a top lymphoma chemotherapy specialist in Israel involves selecting board-certified hematologists at JCI-accredited centers like Sourasky, Sheba, or Hadassah. You can secure appointments with experts who hold fellowships from institutions like Stanford or Memorial Sloan Kettering via Bookimed coordination services.
Bookimed Expert Insight: Data shows that top Israeli hematologists often hold dual research-clinical roles at university hospitals. For example, Prof. Dina Ben-yehuda at Hadassah and Prof. Arnon Nagler Md at Sheba both lead major departments while maintaining active research in gene therapy. This combination ensures patients receive treatment protocols that incorporate the newest scientific findings before they become standard elsewhere.
Patient Consensus: Patients emphasize the importance of having pathology reports ready in English to speed up the matching process with specialists. Many note that choosing university hospitals provides a multidisciplinary team approach that feels more thorough than private clinics. They often feel relieved by how quickly international coordinators can organize the first consultation once records are submitted.